Focused Asset Management Advisory Research Investment Management specializes in actively managed, high-conviction equity portfolios, presenting opportunities to collaborate with firms seeking bespoke investment solutions and specialized actively managed strategies.

Recent Asset Acquisitions The firm has made recent stakes in innovative sectors such as biotechnology with 23andMe and vaccine development with Vaxcyte, indicating potential interest in expanding relationships with biotech and healthcare-focused investors or asset managers.

Growth and Revenue With annual revenues estimated between 100 million and 250 million dollars, Advisory Research shows significant market positioning, making them a potential partner for premium financial services, technology, or consulting vendors looking to target mid-size asset managers.

Technology Utilization Leveraging platforms like AWS and HubSpot Analytics, the firm demonstrates a modern technology stack, suggesting openness to digital transformation initiatives and technology partnerships aimed at data analytics, client engagement, and portfolio management.

Ownership and Culture As a 100% employee-owned company, Advisory Research values expertise and collaborative culture, offering opportunities for tailored professional services, training, or incentive programs that align with employee-driven organizations seeking long-term partner relationships.